Results 11 to 20 of about 4,508,328 (306)

Molecular Pharmacology at the Crossroads of Precision Medicine [PDF]

open access: yesCurrent Issues in Molecular Biology
Molecular pharmacology sits at the nexus of fundamental molecular science and therapeutic innovation [...]
Alina Crenguţa Nicolae   +2 more
doaj   +3 more sources

Molecular Pharmacology in Diabetes. [PDF]

open access: yesInt J Mol Sci
This Special Issue highlights the key molecules and molecular signaling pathways associated with diabetes and its multifaceted complications [...]
Reis F, Fernandes R.
europepmc   +4 more sources

Experimental training in molecular pharmacology education based on drug–target interactions [PDF]

open access: yesPharmacology Research & Perspectives, 2023
Introduction Drug development has been challenged by the dual drawbacks involving unpredictable disease outcomes and drug resistance, which has placed greater demands on pharmacology education.
Luna Ge   +6 more
doaj   +2 more sources

Integrative analysis of Trichosanthes kirilowii maxim formula granules’ anti-triple-negative breast cancer mechanism via network pharmacology, metabolomics, and molecular pharmacology [PDF]

open access: yesFrontiers in Pharmacology
BackgroundTriple-negative breast cancer (TNBC) urgently needs effective therapies due to limited targeted options and unfavorable outcomes. We investigated Trichosanthes kirilowii Maxim formula granules (TKM) using integrated network pharmacology ...
Yuzhen Gao   +11 more
doaj   +2 more sources

Molecular pharmacology of GPCRs. [PDF]

open access: yesBr J Pharmacol, 2018
Linked ArticlesThis article is part of a themed section on Molecular Pharmacology of GPCRs. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.21 ...
Langmead CJ, Summers RJ.
europepmc   +4 more sources

Chemotranscriptomic analysis of 7-hydroxymatairesinol-related effects on MCF7 human breast tumor cells

open access: yesАкушерство, гинекология и репродукция, 2023
Introduction. Establishing the effects of anticancer drugs on the transcriptome is an important procedure in postgenomic pharmacology necessary to comprehensively assess the desired and undesirable effects of candidate drugs.
I. Yu. Torshin   +2 more
doaj   +1 more source

Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists

open access: yesMolecules, 2021
The delta opioid receptor (DOR) is a crucial receptor system that regulates pain, mood, anxiety, and similar mental states. DOR agonists, such as SNC80, and DOR-neutral antagonists, such as naltrindole, were developed to investigate the DOR in vivo and ...
Parthasaradhireddy Tanguturi   +5 more
doaj   +1 more source

29th Annual GP2A Medicinal Chemistry Conference

open access: yesPharmaceuticals, 2021
The 29th Annual GP2A (Group for the Promotion of Pharmaceutical chemistry in Academia) Conference was a virtual event this year due to the COVID-19 pandemic and spanned three days from Wednesday 25 to Friday 27 August 2021.
Jean-Jacques Helesbeux   +10 more
doaj   +1 more source

Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593

open access: yesFrontiers in Pharmacology, 2022
Positive allosteric modulation of the type 1 cannabinoid receptor (CB1R) has substantial potential to treat both neurological and immune disorders.
Asher L. Brandt   +10 more
doaj   +1 more source

Transcriptional Activation, Deactivation and Rebound Patterns in Cortex, Hippocampus and Amygdala in Response to Ketamine Infusion in Rats

open access: yesFrontiers in Molecular Neuroscience, 2022
Ketamine, an N-methyl-D-aspartate (NMDA)-receptor antagonist, is a recently revitalized treatment for pain and depression, yet its actions at the molecular level remain incompletely defined.
Jenny J. Kim   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy